Sleep Medicine Reviews
Volume 4, Issue 3 , Pages 263-276 , June 2000

Sleep disturbance in generalized anxiety disorder and its treatment

  • Jaime M. Monti

      Affiliations

    • Clinical Pharmacology and Therapeutics, Clinics Hospital, Montevideo, Uruguay
    • ,
  • Daniel Monti

      Affiliations

    • Department of Psychiatry, The University of Utah at Salt Lake City, USA

References 

  1. National Sleep Foundation . Sleep in America: a national survey of U.S. adults. Princeton, NJ: The Gallup Organization. 1991;
  2. Coleman RM, Roffwarg HP, Kennedy SJ. Sleep-wake disorders based on a polyÍsomnographic diagnosis: a national cooperative study. JAMA. 1982;247:997–1103
  3. Association of Sleep Disorders Centers: Diagnostic Classification of Sleep and Arousal Disorders . Prepared by the Sleep Disorders Classification Committee. Roffwarg H, chairman. Sleep. 1979;2:1–137
  4. American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders, 3rd ed. Washington DC: American Psychiatric Press. 1980;
  5. Buysee DJ, Reynolds CF, Kupfer DJ. Clinical diagnoses in 216 insomnia patients using the international classification of sleep disorders (ICSD), DSM-IV and ICD-10 categories: a report from the APA/NIMH DSM-IV field trial. Sleep. 1994;17:630–637
  6. American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington DC: American Psychiatric Press. 1994;
  7. Mellinger GD, Balter MB, Uhlenhuth EH. Insomnia and its treatment. Arch Gen Psychiatr. 1985;42:225–232
  8. Regier DA, Myers JK, Kramer M. The NIH Epidemiologic Catchment Area (ECA) Program: historical context, major objectives, and study population characteristics. Arch Gen Psychiatr. 1981;38:381–389
  9. Ford DE, Kamerow MD. Epidemiologic study of sleep disturbances and psychiatric disorders. JAMA. 1989;262:1479–1484
  10. Breslau N, Roth T, Rosenthal L. Sleep disturbance and psychiatric disorders: a longitudinal epidemiological study of young adults. Biol Psychiatr. 1996;39:411–418
  11. Robins LN, Helzer JE, Cottler L, Golding E. NIMH Diagnostic Interview Schedule, version III, revised. St Louis: Washington University. 1989;
  12. Ohayon MM. Prevalence of DSM-IV diagnostic criteria of insomnia: distinguishing insomnia related to mental disorders from sleep disorders. J Psychiat Res. 1997;31:333–346
  13. Ohayon M. Use of an expert system (Eval) in mental health epidemiological surveys. In: Barahona P, Veloso M, Bryant J (eds) Medical Informatic in Europe (MIE 94). Proc Twelfth Internat Congr Europ Fed Med Informatics. Lisbon. 1994;174–179
  14. Vollrath M, Wicki W, Angst J. The Zurich Study. VIII. Insomnia: Association with depression, anxiety, somatic syndromes and course of insomnia. Eur Arch Psychiatr Neurol Sci. 1989;239:113–124
  15. Wittchen HU, Essau CA. Epidemiology of anxiety disorders. In: Michels R (ed) Psychiatry. Philadelphia: Lippincott. 1983;1:1–25
  16. Lépine JP, Lellouch J, Lovell A. L»épidémiologie des troubles anxieux et dépressifs dans une population générale française. Confrontations Psychiatr. 1993;35:1–23
  17. Wittchen HU, Zhao S, Kessler RC. DSM-III-R generalized anxiety disorder in the National Comorbidity Survey. Arch Gen Psychiatr. 1994;51:355–364
  18. American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders, revised, 3rd ed. Washington DC: American Psychiatric Press. 1987;
  19. Uhlenhuth EH, Balter MB, Mellinger GD. Symptom checklist syndromes in the general population: correlations with psychotherapeutic drug use. Arch Gen Psychiatr. 1983;40:1167–1173
  20. Copeland JRM, Gurland BJ, Dewey ME. Is there more dementia, depression and neurosis in New York? A comparative study of the elderly in New York and London using the computer diagnosis AGACAT. Br J Psychiatr. 1987;151:466–473
  21. Regier DA, Boyd JH, Burk JD. One-month prevalence of mental disorders in the United States: based on five epidemiological catchment area sites. Arch Gen Psychiatr. 1988;45:977–986
  22. Lépine J-P, Pélissolo A. Epidemiology and public health impact of anxiety disorders in late life. In: Brunello N, Langer SZ, Racagni G (eds) Mental Disorders in the Elderly: New Therapeutic Approaches. Int Acad Biomed Drug Res. Basel: Karger. 1998;13:43–50
  23. Burke KC, Burke JD, Regier DA. Age at onset of selected mental disorders in five community populations. Arch Gen Psychiatr. 1990;47:511–518
  24. Thyer BA, Parrish RT, Curtis GC. Ages of onset of DSM-III anxiety disorders. Compr Psychiatr. 1985;26:113–122
  25. Barlow DH, Wincze J. DSM-IV and beyond: what is generalized anxiety disorder?. Acta Psychiatr Scand. 1998;98 (Suppl. 393):23–29
  26. Anderson DJ, Noyes R, Crowe RR. A comparison of panic disorder and generalized anxiety disorder. Am J Psychiatr. 1984;141:572–575
  27. Hoehn-Saric R, McLeod DR. Generalized anxiety disorder in adulthood. In: Hersen M, Last CG (eds) Handbook of Child and Adult Psychopathology: A Longitudinal Perspective. New York: Pergamon Press. 1990;247–260
  28. Soldatos CR. Insomnia in relation to depression and anxiety: epidemiologic consideration. J Psychosom Res. 1994;38 (Suppl. 1):3–8
  29. Morin CM, Ware JC. Sleep and psychopathology. Appl Prevent Psychol. 1996;5:221–224
  30. Arriaga F, Paiva T. Clinical and EEG sleep changes in primary dysthymia and generalized anxiety: a comparison with normal controls. Biol Psychiatr. 1990;91:109–114
  31. Spitzer RL, Endicott J, Robins E. Research Diagnostic Criteria: rationale and reliability. Arch Gen Psychiatr. 1978;38:773–779
  32. Papadimitriou GN, Kerkhofs M, Kempenaers C. EEG sleep studies in patients with generalized anxiety disorder. Psychiatr Res. 1988;26:183–190
  33. Speilberger C. Manual for the state-trait anxiety inventory (TAI form Y). Palo Alto: Consulting Psychologists Press. 1983;
  34. Fuller KH, Waters WF, Binks PG. Generalized anxiety and sleep architecture: a polysomnographic investigation. Sleep. 1997;20:370–376
  35. World Health Organization . International statistical classification of diseases and related health problems (ICD-9), 9th ed. Geneva: World Health Organization. 1975;
  36. Saletu B, Anderer P, Brandstätter ?. Insomnia in generalized anxiety disorder: polyÍsomnographic psychometric and clinical investigations before, during and after therapy with a long- versus a short-half life benzodiazepine (quazepam versus triazolam). Neuropsychobiology. 1994;29:69–90
  37. World Health Organization . International statistical classification of diseases and related health problems (ICD-10), 10th ed. Geneva: World Health Organization. 1992;
  38. Saletu-Zyhlarz G, Saletu B, Anderer P. Nonorganic insomnia in generalized anxiety disorder. Neuropsychobiology. 1997;36:117–129
  39. Derogatis LE, Lipman RS, Rickel K. The Hopkins Symptom Checklist (HSCL): a measure of primary symptom dimensions. Modern Problems in Pharmacopsychiatry. 1974;7:79–110
  40. Rosa RR, Bonnet MH, Kramer M. The relationship of sleep and anxiety in anxious subjects. Biol Psychol. 1983;16:119–126
  41. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol. 1959;32:50–55
  42. Brown T, Antony M, Barlow D. Psychometric properties of the Penn State worry questionnaire in a clinical anxiety disorders sample. Behav Res Ther. 1992;30:33–37
  43. Rechtschaffen A, Kales A. A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages in Human Subjects. NIH Publ 204. NIH Publ 204. Washington DC: US Government Printing Office. 1968;
  44. Colby KM. A Primer for Psychotherapists. New York: Ronald Press. 1951;
  45. Jacobson E. Progressive Relaxation. Chicago: University of Chicago Press. 1938;
  46. Wolpe J. Psychotherapy by Reciprocal Inhibition. Stanford: Stanford University Press. 1958;
  47. Canter A, Kondo CY, Knott JR. A comparison of EMG feedback and progressive relaxation training in anxiety neurosis. Br J Psychiatr. 1975;127:470–477
  48. Townsend RE, House JF, Addario D. A comparison of biofeedback-mediated relaxation and group therapy in the treatment of chronic anxiety. Am J Psychiatr. 1975;132:598–601
  49. Raskin M, Bali LR, Peeke HV. Muscle biofeedback and transcendental meditation. Arch Gen Psychiatr. 1980;37:93–97
  50. Lehrer PM, Woolfolk RL, Rooney AJ. Progressive relaxation and meditation: a study of psychophysiological and therapeutic differences between two techniques. Behav Res Ther. 1983;21:651–662
  51. Tarrier N, Main CJ. Applied relaxation training for generalized anxiety and panic attacks: the efficacy of learnt coping strategy on subjective reports. Br J Psychiatr. 1986;149:330–336
  52. Butler G, Cullington A, Hibbert G. Anxiety management for persistent generalized anxiety. Br J Psychiatr. 1987;151:535–542
  53. Beck AT, Emery G. Anxiety Disorders and Phobias: A Cognitive Perspective. New York: Basic Books. 1985;
  54. Blowers C, Cobb J, Mathews A. Generalized anxiety: a controlled treatment study. Behav Res Ther. 1987;25:493–502
  55. Borkovec TD, Costello E. Efficacy of applied relaxation and cognitive behavioral therapy in the treatment of generalized anxiety disorder. J Consult Clin Psychol. 1993;61:611–619
  56. Power KG, Jerrom DW, Simpson RJ. A controlled comparison of cognitive behavior therapy, diazepam and placebo in the management of generalized anxiety. Behav Psychother. 1989;17:1–14
  57. Power KG, Simpson MB, Swanson V. A controlled comparison of cognitive behavior therapy, diazepam and placebo, alone and in combination, for the treatment of generalized anxiety disorder. J Anxiety Disorders. 1990;4:269–292
  58. Borkovec TD, Mathews AM, Chambers A. The effects of relaxation training with cognitive therapy or nondirective therapy and the role of relaxation-induced anxiety in the treatment of generalized anxiety. J Consult Clin Psychol. 1987;25:883–888
  59. Butler G, Gennell M, Robson P. Comparison of behavior therapy and cognitive behavior therapy in the treatment of generalized anxiety disorder. J Consult Clin Psychol. 1994;49:439–440
  60. Hoehn-Saric R, McLeod DR, Simmerli WD. Differential effects of alprazolam and imipramine in generalized anxiety disorder: somatic versus psychic symptoms. J Clin Psychiatr. 1988;49:293–301
  61. Rickels K, Downing R, Schweizer E. Antidepressants for the treatment of generalized anxiety disorder. Arch Gen Psychiatr. 1993;50:884–895
  62. Lader M. Benzodiazepines. A risk-benefit profile. CNS Drugs. 1994;1:377–387
  63. Lader MH. The nature and duration of treatment of GAD. Acta Psychiatr Scand. 1998;98 (Suppl. 393):109–117
  64. Rickels K, Schweizer E. Long-term treatment of anxiety disorder. Psychopharmacol Bull. 1995;31:115–123
  65. Schweizer E, Rickels K. The long-term management of generalized anxiety disorder: issues and dilemmas. J Clin Psychiatr. 1996;57 (Suppl. 7):9–12
  66. Monti JM, Monti D. Pharmacological treatment of chronic insomnia. CNS Drugs. 1995;4:182–194
  67. Durham RC, Allan T. Psychological treatment of generalized anxiety disorder. A review of the clinical significance of results in outcome studies since 1980. Br J Psychiatr. 1986;163:19–26
  68. Cassano GB, Michelini S. Pharmacological treatment of depression and comorbid anxiety disorders. In: Gessa G, Fratta W, Pani L, Serra G (eds) Depression and Mania: From Neurobiology to Treatment. New York: Raven Press. 1995;113–125

PII: S1087-0792(99)90096-5

doi: 10.1053/smrv.1999.0096

Sleep Medicine Reviews
Volume 4, Issue 3 , Pages 263-276 , June 2000

Article Tools